Chloroquine has been extensively used in mass drug administrations, which may have contributed to the emergence and spread of resistance. It is recommended to check if chloroquine is still effective in the region prior to using it. Plaquenil and watery eyes How long is it safe to take plaquenil Chloroquine other drugs in same class The Lupus Foundation of America is aware of the potential use of hydroxychloroquine Plaquenil and chloroquine Aralen for the treatment of coronavirus COVID-19. This means that these drugs may be in high demand in the coming weeks. We are actively working with our medical and scientific. Hydroxychloroquine Plaquenil Chloroquine Aralen Quinacrine Atabrine What are anti-malarial drugs, and why are they used to treat lupus? Hydroxychloroquine Plaquenil, chloroquine Aralen, and quinacrine Atabrine are medications that were originally used to prevent or treat malaria. Chloroquine, which is made by one manufacturer in the US and was approved in the country in 1949, has been in shortage since March 9, according to the American Society of Health-System Pharmacists. The Centers for Disease Control and Prevention recommend against treatment of malaria with chloroquine alone due to more effective combinations. In areas where resistance is present, other antimalarials, such as mefloquine or atovaquone, may be used instead. Chloroquine for lupus treatment Chloroquine shortage coronavirus treatment, lupus., Treating Lupus with Anti-Malarial Drugs Johns Hopkins Lupus Center Chloroquine and primaquineHydroxychloroquine and eyesProphylaxis for chloroquine resistant malariaAlcohol dehydrogenase chloroquine Plaquenil hydroxychloroquine is commonly used to help keep mild lupus-related problems, such as skin and joint disease, under control. this drug is also effective at preventing lupus flares. How is plaquenil hydroxychloroquine used to treat lupus?. Chloroquine shortage coronavirus treatment, lupus, arthritis.. Hydroxychloroquine DermNet NZ. Chloroquine is a medication first developed as an anti-malarial that has been used for many years to help treat lupus systemic lupus erythematosus, or SLE and rheumatoid arthritis. If a patient responds to treatment with an anti-malarial, in general it will continue to be used indefinitely. Systemic lupus erythematosus is a disease that continues to evolve over time. Thus, a patient who presents with skin and joint disease remains at risk for renal disease even after having lupus. In 1941, discoid lupus patients were treated successfully with Atabrine, a compound developed in Germany in the 1920s. In the mid-1940s, both hydroxychloroquine HCQ and chloroquine CQ had been synthesized. In 1955 HCQ was shown to be effective for both systemic lupus and rheumatoid arthritis.